Gilead Dives After Its Bread-And-Butter Drug Misses Sales Forecasts
In This Article:
Two of Gilead Sciences' most important drugs missed sales expectations late Thursday. Gilead stock fell in late action.
Oops, something went wrong
Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Two of Gilead Sciences' most important drugs missed sales expectations late Thursday. Gilead stock fell in late action.